FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1574672214> ?p ?o ?g. }

• W1574672214 endingPage "9408" @default.
• W1574672214 startingPage "9397" @default.
• W1574672214 abstract "// Otto L.D. Cerqueira 1 , Peter Truesdell 2 , Tomas Baldassarre 2 , Santiago A. Vilella-Arias 1 , Kathleen Watt 2 , Jalna Meens 2 , Harish Chander 2 , Cynthia A.B. Osório 3 , Fernando A. Soares 3, 4 , Eduardo M. Reis 1, 4 , Andrew W.B. Craig 2 1 Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil 2 Department of Biomedical and Molecular Sciences, Queen's University, and Division of Cancer Biology & Genetics, Queen's Cancer Research Institute, Kingston, ON, Canada 3 Department of Anatomic Pathology, A.C. Camargo Hospital, São Paulo, SP, Brazil 4 Instituto Nacional de Ciência e Tecnologia em Oncogenômica, São Paulo, SP, Brazil Correspondence to: Andrew W. Craig, e-mail: andrew.craig@queensu.ca Eduardo M. Reis, e-mail: emreis@iq.usp.br Keywords: metastasis, triple-negative breast cancer, CIP4 Received: October 22, 2014      Accepted: February 10, 2015      Published: March 19, 2015 ABSTRACT Signaling via epidermal growth factor receptor (EGFR) and Src kinase pathways promote triple-negative breast cancer (TNBC) cell invasion and tumor metastasis. Here, we address the role of Cdc42-interacting protein-4 (CIP4) in TNBC metastasis in vivo , and profile CIP4 expression in human breast cancer patients. In human TNBC cells, CIP4 knock-down (KD) led to less sustained activation of Erk kinase and impaired cell motility compared to control cells. This correlated with significant defects in 3D invasion of surrounding extracellular matrix by CIP4 KD TNBC cells when grown as spheroid colonies. In mammary orthotopic xenograft assays using both human TNBC cells (MDA-MB-231, HCC 1806) and rat MTLn3 cells, CIP4 silencing had no overt effect on tumor growth, but significantly reduced the incidence of lung metastases in each tumor model. In human invasive breast cancers, high CIP4 levels was significantly associated with high tumor stage, TNBC and HER2 subtypes, and risk of progression to metastatic disease. Together, these results implicate CIP4 in promoting metastasis in TNBCs." @default.
• W1574672214 created "2016-06-24" @default.
• W1574672214 creator A5000803349 @default.
• W1574672214 creator A5028135099 @default.
• W1574672214 creator A5030577458 @default.
• W1574672214 creator A5044640197 @default.
• W1574672214 creator A5051845053 @default.
• W1574672214 creator A5060723951 @default.
• W1574672214 creator A5074333712 @default.
• W1574672214 creator A5075051417 @default.
• W1574672214 creator A5084997825 @default.
• W1574672214 creator A5085071694 @default.
• W1574672214 creator A5090706721 @default.
• W1574672214 date "2015-03-19" @default.
• W1574672214 modified "2023-09-27" @default.
• W1574672214 title "CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis" @default.
• W1574672214 cites W1532822464 @default.
• W1574672214 cites W1981989535 @default.
• W1574672214 cites W1984102131 @default.
• W1574672214 cites W1993667346 @default.
• W1574672214 cites W2004096690 @default.
• W1574672214 cites W2004344365 @default.
• W1574672214 cites W2007897263 @default.
• W1574672214 cites W2013221473 @default.
• W1574672214 cites W2019458473 @default.
• W1574672214 cites W2023040358 @default.
• W1574672214 cites W2024953815 @default.
• W1574672214 cites W2025224715 @default.
• W1574672214 cites W2027631050 @default.
• W1574672214 cites W2028048786 @default.
• W1574672214 cites W2028236537 @default.
• W1574672214 cites W2037510648 @default.
• W1574672214 cites W2043409879 @default.
• W1574672214 cites W2044441651 @default.
• W1574672214 cites W2046345458 @default.
• W1574672214 cites W2053527054 @default.
• W1574672214 cites W2055498399 @default.
• W1574672214 cites W2056464773 @default.
• W1574672214 cites W2063804661 @default.
• W1574672214 cites W2065017228 @default.
• W1574672214 cites W2083713591 @default.
• W1574672214 cites W2106617370 @default.
• W1574672214 cites W2112229259 @default.
• W1574672214 cites W2118903478 @default.
• W1574672214 cites W2120512382 @default.
• W1574672214 cites W2131994307 @default.
• W1574672214 cites W2133650808 @default.
• W1574672214 cites W2134539328 @default.
• W1574672214 cites W2136270276 @default.
• W1574672214 cites W2137654068 @default.
• W1574672214 cites W2139517025 @default.
• W1574672214 cites W2144996654 @default.
• W1574672214 cites W2150026933 @default.
• W1574672214 cites W2158897126 @default.
• W1574672214 cites W2161426850 @default.
• W1574672214 cites W2165948908 @default.
• W1574672214 cites W2167852809 @default.
• W1574672214 cites W2170345729 @default.
• W1574672214 doi "https://doi.org/10.18632/oncotarget.3351" @default.
• W1574672214 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4496225" @default.
• W1574672214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25823823" @default.
• W1574672214 hasPublicationYear "2015" @default.
• W1574672214 type Work @default.
• W1574672214 sameAs 1574672214 @default.
• W1574672214 citedByCount "27" @default.
• W1574672214 countsByYear W15746722142016 @default.
• W1574672214 countsByYear W15746722142017 @default.
• W1574672214 countsByYear W15746722142018 @default.
• W1574672214 countsByYear W15746722142019 @default.
• W1574672214 countsByYear W15746722142020 @default.
• W1574672214 countsByYear W15746722142021 @default.
• W1574672214 countsByYear W15746722142022 @default.
• W1574672214 countsByYear W15746722142023 @default.
• W1574672214 crossrefType "journal-article" @default.
• W1574672214 hasAuthorship W1574672214A5000803349 @default.
• W1574672214 hasAuthorship W1574672214A5028135099 @default.
• W1574672214 hasAuthorship W1574672214A5030577458 @default.
• W1574672214 hasAuthorship W1574672214A5044640197 @default.
• W1574672214 hasAuthorship W1574672214A5051845053 @default.
• W1574672214 hasAuthorship W1574672214A5060723951 @default.
• W1574672214 hasAuthorship W1574672214A5074333712 @default.
• W1574672214 hasAuthorship W1574672214A5075051417 @default.
• W1574672214 hasAuthorship W1574672214A5084997825 @default.
• W1574672214 hasAuthorship W1574672214A5085071694 @default.
• W1574672214 hasAuthorship W1574672214A5090706721 @default.
• W1574672214 hasBestOaLocation W15746722141 @default.
• W1574672214 hasConcept C121608353 @default.
• W1574672214 hasConcept C126322002 @default.
• W1574672214 hasConcept C143998085 @default.
• W1574672214 hasConcept C184235292 @default.
• W1574672214 hasConcept C2779013556 @default.
• W1574672214 hasConcept C2780110267 @default.
• W1574672214 hasConcept C502942594 @default.
• W1574672214 hasConcept C530470458 @default.
• W1574672214 hasConcept C71924100 @default.
• W1574672214 hasConcept C86803240 @default.
• W1574672214 hasConcept C95444343 @default.
• W1574672214 hasConceptScore W1574672214C121608353 @default.

• next